Biomed-Lublin

Activity by year

201820192020202120222023202420252026

ContractExpansion

Feb 13, 2018EXPANSIONPolandops Q3 2018
Biomed-Lublin to double Distreptaza production with new line
Biomed-Lublin is investing in a new Distreptaza production line that will double output and start operations in Q3 2018.
Biomed-Lublin rp.pl
Feb 13, 2018CONTRACTPoland$13.0M
Bioton signs distribution deal for Biomed-Lublin's Distreptaza
Biomed-Lublin signed a distribution agreement with Bioton for the sale of Distreptaza in Poland, valued at approximately PLN 45 million, valid until end of 2022. Biomed also announced a new production line for Distreptaza will start in Q3 2018.
Biomed-Lublin customer Bioton supplier rp.pl
Feb 12, 2018CONTRACTPoland$13.0M
Biomed-Lublin signs distribution deal with Bioton for Distreptaza in Poland
Biomed-Lublin signed a cooperation agreement with Bioton for the sale and distribution of Distreptaza in Poland until end of 2022, with a total estimated value of about 45 million PLN. Biomed will also launch a new Distreptaza production line in Q3 2018, doubling capacity.
Biomed-Lublin supplier Bioton customer #Medical Devices bankier.pl

Site	Largest	Latest
Poland		2018-02-13

Customers

Suppliers

Loading…